NCT04150731View on ClinicalTrials.gov

16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

October 25, 2022

Study Completion Date

June 28, 2023

Conditions
Breast Cancer
Interventions
RADIATION

16α-18F-fluor-17β-estradiol

16α-18F-fluor-17β-estradiol PET/CT scan

Trial Locations (1)

8200

Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus N

All Listed Sponsors
collaborator

GCP-unit at Aarhus University Hospital, Aarhus, Denmark

OTHER

collaborator

REDCap

UNKNOWN

lead

University of Aarhus

OTHER

NCT04150731 - 16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer | Biotech Hunter | Biotech Hunter